2nd Webinar: IASLC Lung Cancer Grand Rounds Series - Management of Patients with ALK Positive NSCLC
The second webinar in the series, Management of ALK Positive NSCLC took place on February 10, 2014. The recording is available below. Ramaswamy Govindan, MD moderated the session, and Alice Shaw, MD,PhD briefly reviewed ALK Positive NSCLC and presented several patient case studies for discussion.
Alice Shaw, MD, PhD
Associate Professor of Medicine, Massachusetts General Hospital and Harvard Medical School
Ramaswamy Govindan, MD
Co-Director, Section of Medical Oncology
Professor of Medicine, Division of Oncology
Washington University School of Medicine
This CME live webinar series is designed to meet the educational needs of healthcare professionals who diagnose and treat patients with lung cancer, including medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, radiologists, pathologists and advanced practice nurses and physicians' assistants.
The second webinar in the series, Management of ALK Positive NSCLC will take place on February 10, 2014. Ramaswamy Govindan, MD will moderate the session, and Alice Shaw, MD, PhD will briefly review ALK Positive NSCLC, discuss resistance to ALK inhibitors, and present several patient case studies for discussion.
Fourteen grand rounds webinars in total will be held in 2014 as part of this new educational series, from January-December 2014. Participants who complete a pre-and post-test along with an evaluation will receive 1 AMA PRA Category 1 CreditTM for each completed webinar.
This series is supported in part by unrestricted educational grants provided by Bristol-Myers Squibb Co., Celgene and Genentech